DOCSLIB.ORG

Identification of TUBB2A by Quantitative Proteomic Analysis As A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Identification of TUBB2A by Quantitative Proteomic Analysis As A Shin et al. Clin Proteom (2020) 17:16 https://doi.org/10.1186/s12014-020-09280-z Clinical Proteomics RESEARCH Open Access Identifcation of TUBB2A by quantitative proteomic analysis as a novel biomarker for the prediction of distant metastatic breast cancer Dongyoon Shin1†, Joonho Park2†, Dohyun Han3, Ji Hye Moon4, Han Suk Ryu4* and Youngsoo Kim1,2* Abstract Background: Metastasis of breast cancer to distal organs is fatal. However, few studies have identifed biomarkers that are associated with distant metastatic breast cancer. Furthermore, the inability of current biomarkers, such as HER2, ER, and PR, to diferentiate between distant and nondistant metastatic breast cancers accurately has necessi- tated the development of novel biomarker candidates. Methods: An integrated proteomics approach that combined flter-aided sample preparation, tandem mass tag labeling (TMT), high pH fractionation, and high-resolution MS was applied to acquire in-depth proteomic data from FFPE distant metastatic breast cancer tissues. A bioinformatics analysis was performed with regard to gene ontology and signaling pathways using diferentially expressed proteins (DEPs) to examine the molecular characteristics of dis- tant metastatic breast cancer. In addition, real-time polymerase chain reaction (RT-PCR) and invasion/migration assays were performed to validate the diferential regulation and function of our protein targets. Results: A total of 9441 and 8746 proteins were identifed from the pooled and individual sample sets, respectively. Based on our criteria, TUBB2A was selected as a novel biomarker candidate. The metastatic activities of TUBB2A were subsequently validated. In our bioinformatics analysis using DEPs, we characterized the overall molecular features of distant metastasis and measured diferences in the molecular functions of distant metastatic breast cancer between breast cancer subtypes. Conclusions: Our report is the frst study to examine the distant metastatic breast cancer proteome using FFPE tis- sues. The depth of our dataset allowed us to discover a novel biomarker candidate and a proteomic characteristics of distant metastatic breast cancer. Distinct molecular features of various breast cancer subtypes were also established. Our proteomic data constitute a valuable resource for research on distant metastatic breast cancer. Keywords: Distant metastatic breast cancer, Formalin-fxed parafn-embedded (FFPE) tissue, Biomarkers, Tandem mass tag (TMT), Quantitative proteomics Background *Correspondence: [email protected]; [email protected] Breast cancer is one of the most prevalent and lethal can- †Dongyoon Shin and Joonho Park contributed equally to this work 1 Department of Biomedical Sciences, Seoul National University College cers in women worldwide [1]. In particular, its annual of Medicine, 103 Daehakro, Seoul 30380, Korea incidence—currently 17 million cases—is increasing at 4 Department of Pathology, Seoul National University Hospital, 101 an alarming rate [2, 3]. Tere are approximately 232,000 Daehakro, Seoul 03080, Korea Full list of author information is available at the end of the article new cases of invasive breast cancer each year in the US, © The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/ zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. Shin et al. Clin Proteom (2020) 17:16 Page 2 of 19 and approximately 40,000 women die each year from recent report has described a low correlation between the disease; furthermore, roughly 90% of these deaths proteomes and transcriptomes in human breast cancer are caused by the most malignant form of breast cancer: tissues, suggesting that a proteomic approach to human distant metastatic breast cancer [2, 4]. Distant metastatic BC tissues could complement a transcriptomic method breast cancer, which preferentially metastasizes to distal [29]. organs, such as the bone, liver, lung, and brain, has a poor Although proteomic studies have been performed for prognosis [5, 6]. In addition, this type of breast cancer various diseases, including breast cancer, none has inves- causes various complications at the afected sites, such tigated the overall characteristics of distant metastatic as pericardial efusion, pleural efusion, bone fracture, breast cancer [29–37, 44]. Proteomic research is expected hypercalcemia, and red blood cell anemia, which worsens to provide greater insight into the pathogenesis of distant survival outcomes [7–9]. metastatic breast cancer, generating novel information Distant metastatic breast cancer is assessed, based on about the molecular features of distant metastasis—for various factors, such as tumor size, lymphovascular inva- example, by discovering novel protein biomarkers for the sion, histological grade, nodal involvement, and hormone prediction or diagnosis of distant metastatic breast can- receptor status—all of which are independent risk fac- cer. Tus, an in-depth proteomic analysis is important for tors for distant metastatic breast cancer [10–13]. Among yielding valuable resources in distant metastatic breast these factors, breast cancer molecular subtypes are asso- cancer—data that have not been found in genomic and ciated with various patterns of distant metastatic spread transcriptomic analyses. and related to diferences in survival outcomes [10, 14]. Recent advances in mass spectrometry (MS)-based For instance, the most widely known molecular subtypes, proteomics have accelerated the development of high- such as the luminal A, luminal B, HER2, and basal-like throughput techniques for proteomic quantifcation [38, (triple-negative) groups, have site-specifc, cumulative 39]. In addition, a tandem mass tag (TMT)-based strat- metastatic incidence rates, demonstrating substantial dif- egy has facilitated relative protein quantifcation by com- ferences in the distant metastatic behavior of and overall paring the reporter ion intensities that are obtained by survival between breast cancer subtypes [10]. MS/MS. Because this approach can quantify thousands Although various risks and molecular characteristics of proteins precisely with high sensitivity, TMT-based of distant metastatic breast cancer have been established, techniques have been used widely to generate substan- the prediction and diagnosis of distant metastasis in tial datasets [40–43]. With a 6-plex TMT quantifcation breast cancer with molecular biomarkers remain largely technique, in combination with high-resolution MS, we unexamined [4–6, 10–13]. Tus, characterizing the constructed an in-depth proteomic map of distant meta- molecular signatures that are associated with distant static breast cancer. metastasis using omics-based approaches, such as In this study, we hypothesized that in-depth proteomic genomics, transcriptomics, and proteomics, might iden- data would supply important proteins to profle the tify previously overlooked biomarker candidates. molecular signatures of distant metastatic breast cancer. Many genomic or transcriptomic studies have exam- Using our proteomic techniques, we identifed by far the ined the molecular characteristics of distant meta- largest number of proteins from FFPE distant and non- static breast cancer—for instance, genes that are distant metastatic breast cancer tissues. Furthermore, we associated with lung, brain, and bone metastasis from determined important protein targets to validate distant breast tumor [15–18, 20, 21]. In addition, genetic sig- metastatic potential of breast cancer. Te function of natures that predict distant metastasis in breast cancer these targets was determined using several approaches, have been established through genomic profling [19]. including RT-PCR and invasion/migration assays. However, given the relatively low correlation between Trough our criteria to narrow down the important gene expression and protein expression, it is difcult to proteins, we discovered a novel protein biomarker can- assume that the tendencies in genomic data will trans- didate diferentially expressed in distant metastatic breast late fully to proteomic data without verifcation [22, cancer. Furthermore, we examined the distinct biologi- 23]. Similarly, considering that transcriptomic and pro- cal functions of distant metastatic breast cancer between teomic data have a moderate correlation, the molecular molecular subtypes. In summary, we have proposed the characteristics of the transcriptome could not perfectly frst protein biomarker candidate that potentially be able represent those of the proteome [24–26]. In the case to distinguish distant metastasis, derived from primary of breast cancer,
Load more

Recommended publications
  • University of California, San Diego
    UC San Diego UC San Diego Electronic Theses and Dissertations Title The post-terminal differentiation fate of RNAs revealed by next-generation sequencing Permalink https://escholarship.org/uc/item/7324r1rj Author Lefkowitz, Gloria Kuo Publication Date 2012 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, SAN DIEGO The post-terminal differentiation fate of RNAs revealed by next-generation sequencing A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Biomedical Sciences by Gloria Kuo Lefkowitz Committee in Charge: Professor Benjamin D. Yu, Chair Professor Richard Gallo Professor Bruce A. Hamilton Professor Miles F. Wilkinson Professor Eugene Yeo 2012 Copyright Gloria Kuo Lefkowitz, 2012 All rights reserved. The Dissertation of Gloria Kuo Lefkowitz is approved, and it is acceptable in quality and form for publication on microfilm and electronically: __________________________________________________________________ __________________________________________________________________ __________________________________________________________________ __________________________________________________________________ __________________________________________________________________ Chair University of California, San Diego 2012 iii DEDICATION Ma and Ba, for your early indulgence and support. Matt and James, for choosing more practical callings. Roy, my love, for patiently sharing the ups and downs
    [Show full text]
  • Frequent Loss-Of-Heterozygosity in CRISPR-Cas9–Edited Early Human Embryos
    Frequent loss-of-heterozygosity in CRISPR-Cas9–edited COLLOQUIUM PAPER early human embryos Gregorio Alanis-Lobatoa, Jasmin Zohrenb, Afshan McCarthya, Norah M. E. Fogartya,c, Nada Kubikovad,e, Emily Hardmana, Maria Grecof, Dagan Wellsd,g, James M. A. Turnerb, and Kathy K. Niakana,h,1 aHuman Embryo and Stem Cell Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom; bSex Chromosome Biology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom; cCentre for Stem Cells and Regenerative Medicine, Guy’s Campus, King’s College London, SE1 9RT London, United Kingdom; dNuffield Department of Women’s and Reproductive Health, John Radcliffe Hospital, University of Oxford, OX3 9DU Oxford, United Kingdom; eJesus College, University of Oxford, OX1 3DW Oxford, United Kingdom; fAncient Genomics Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom; gJuno Genetics, OX4 4GE Oxford, United Kingdom; and hThe Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, CB2 3EG Cambridge, United Kingdom Edited by Barbara J. Meyer, University of California, Berkeley, CA, and approved October 31, 2020 (received for review June 5, 2020) CRISPR-Cas9 genome editing is a promising technique for clinical homozygous WT embryos in both cases was not associated with applications, such as the correction of disease-associated alleles in use of the provided repair template for gene correction. Instead, somatic cells. The use of this approach has also been discussed in the authors suggest that in edited embryos the WT maternal the context of heritable editing of the human germ line. However, allele served as a template for the high-fidelity homology di- studies assessing gene correction in early human embryos report rected repair (HDR) pathway to repair the double-strand lesion low efficiency of mutation repair, high rates of mosaicism, and the caused by the Cas9 protein in the paternal allele (8).
    [Show full text]
  • Gender-Specific Expression of Ubiquitin-Specific Peptidase 9 Modulates Tau Expression and Phosphorylation: Possible Implications for Tauopathies
    Mol Neurobiol DOI 10.1007/s12035-016-0299-z Gender-Specific Expression of Ubiquitin-Specific Peptidase 9 Modulates Tau Expression and Phosphorylation: Possible Implications for Tauopathies Sandra Köglsberger1 & Maria Lorena Cordero-Maldonado1 & Paul Antony1 & Julia Ilona Forster1 & Pierre Garcia 1 & Manuel Buttini1 & Alexander Crawford1 & Enrico Glaab1 Received: 22 May 2016 /Accepted: 14 November 2016 # The Author(s) 2016. This article is published with open access at Springerlink.com Abstract Public transcriptomic studies have shown that sev- literature, we derive a data-congruent model for a USP9-de- eral genes display pronounced gender differences in their ex- pendent regulatory mechanism modulating MAPT expression pression in the human brain, which may influence the mani- via BACH1 and SMAD4. Overall, the analyses suggest USP9 festations and risk for neuronal disorders. Here, we apply a may contribute to molecular gender differences observed in transcriptome-wide analysis to discover genes with gender- tauopathies and provide a new target for intervention strate- specific expression and significant alterations in public post- gies to modulate MAPT expression. mortem brain tissue from Alzheimer’s disease (AD) patients compared to controls. We identify the sex-linked ubiquitin- Keywords Transcriptomics .Tau .Tauopathies .Alzheimer’s specific peptidase 9 (USP9) as an outstanding candidate gene disease . Gender differences . Zebrafish with highly significant expression differences between the genders and male-specific underexpression in
    [Show full text]
  • Datasheet: MCA4184Z Product Details
    Datasheet: MCA4184Z Description: MOUSE ANTI HUMAN TUBULIN BETA 2A CHAIN:Preservative Free Specificity: TUBULIN BETA 2A CHAIN Other names: TUBB2A Format: Preservative Free Product Type: Monoclonal Antibody Clone: 2B2 Isotype: IgG2a Quantity: 0.1 mg Product Details Applications This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit www.bio-rad-antibodies.com/protocols. Yes No Not Determined Suggested Dilution Flow Cytometry Immunohistology - Frozen Immunohistology - Paraffin ELISA Immunoprecipitation Western Blotting 0.1 - 10 ug/ml Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls. Target Species Human Species Cross Reacts with: Rat, Mouse Reactivity N.B. Antibody reactivity and working conditions may vary between species. Product Form Purified IgG - liquid Preparation Purified IgG prepared by affinity chromatography on Protein A Buffer Solution Phosphate buffered saline Preservative None present Stabilisers Approx. Protein IgG concentration 0.5 mg/ml Concentrations Immunogen Recombinant protein with a GST tag corresponding to amino acids 1-446 of human TUBB2A Page 1 of 3 External Database Links UniProt: Q13885 Related reagents Entrez Gene: 7280 TUBB2A Related reagents Synonyms TUBB2 Fusion Partners Spleen cells from BALB/c mice were fused with cells from the Sp2/0 myeloma cell line.
    [Show full text]
  • Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands That Promote Axonal Growth
    Research Article: New Research Development Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands that Promote Axonal Growth Jeremy S. Toma,1 Konstantina Karamboulas,1,ª Matthew J. Carr,1,2,ª Adelaida Kolaj,1,3 Scott A. Yuzwa,1 Neemat Mahmud,1,3 Mekayla A. Storer,1 David R. Kaplan,1,2,4 and Freda D. Miller1,2,3,4 https://doi.org/10.1523/ENEURO.0066-20.2020 1Program in Neurosciences and Mental Health, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada, 2Institute of Medical Sciences University of Toronto, Toronto, Ontario M5G 1A8, Canada, 3Department of Physiology, University of Toronto, Toronto, Ontario M5G 1A8, Canada, and 4Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5G 1A8, Canada Abstract Peripheral nerves provide a supportive growth environment for developing and regenerating axons and are es- sential for maintenance and repair of many non-neural tissues. This capacity has largely been ascribed to paracrine factors secreted by nerve-resident Schwann cells. Here, we used single-cell transcriptional profiling to identify ligands made by different injured rodent nerve cell types and have combined this with cell-surface mass spectrometry to computationally model potential paracrine interactions with peripheral neurons. These analyses show that peripheral nerves make many ligands predicted to act on peripheral and CNS neurons, in- cluding known and previously uncharacterized ligands. While Schwann cells are an important ligand source within injured nerves, more than half of the predicted ligands are made by nerve-resident mesenchymal cells, including the endoneurial cells most closely associated with peripheral axons. At least three of these mesen- chymal ligands, ANGPT1, CCL11, and VEGFC, promote growth when locally applied on sympathetic axons.
    [Show full text]
  • The Microtubule Skeleton and the Evolution of Neuronal Complexity in Vertebrates
    Biol. Chem. 2019; 400(9): 1163–1179 Nataliya I. Trushina, Armen Y. Mulkidjanian and Roland Brandt* The microtubule skeleton and the evolution of neuronal complexity in vertebrates https://doi.org/10.1515/hsz-2019-0149 Received February 4, 2019; accepted April 17, 2019; previously Introduction published online May 22, 2019 The complexity of the nervous system permits the devel- Abstract: The evolution of a highly developed nervous opment of sophisticated behavioral repertoires, such as system is mirrored by the ability of individual neurons to language, tool use, self-awareness, symbolic thought, develop increased morphological complexity. As microtu- cultural learning and consciousness. The basis for the bules (MTs) are crucially involved in neuronal development, development of such a complexity is a high neuronal het- we tested the hypothesis that the evolution of complexity is erogeneity caused by neuronal diversification on the one driven by an increasing capacity of the MT system for regu- hand and a large interconnectivity between the individual lated molecular interactions as it may be implemented by neurons on the other hand (Muotri and Gage, 2006). In a higher number of molecular players and a greater ability addition, the brain constantly needs to adapt to func- of the individual molecules to interact. We performed bio- tional challenges of various kinds during development informatics analysis on different classes of components of and adulthood by a process called neural plasticity (Zilles, the vertebrate neuronal MT cytoskeleton. We show that the 1992). At a single cell level, neural plasticity involves number of orthologs of tubulin structure proteins, MT-bind- changes in the number or the strength of synaptic con- ing proteins and tubulin-sequestering proteins expanded tacts between individual neurons thereby changing the during vertebrate evolution.
    [Show full text]
  • Single-Cell Transcriptome Analysis Reveals Mesenchymal Stem Cells In
    bioRxiv preprint doi: https://doi.org/10.1101/2021.09.02.458742; this version posted September 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Single-cell transcriptome analysis reveals mesenchymal stem cells 2 in cavernous hemangioma 3 Fulong Ji1$, Yong Liu2$, Jinsong Shi3$, Chunxiang Liu1, Siqi Fu1 4 Heng Wang1, Bingbing Ren1, Dong Mi4, Shan Gao2*, Daqing Sun1* 5 1 Department of Paediatric Surgery, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China. 6 China. 7 2 College of Life Sciences, Nankai University, Tianjin, Tianjin 300071, P.R. China; 8 3 National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of 9 Medicine, Nanjing, Jiangsu 210016, P.R. China; 10 4 School of Mathematical Sciences, Nankai University, Tianjin, Tianjin 300071, P.R. China; 11 12 13 $ These authors contributed equally to this paper. 14 * Corresponding authors. 15 SG：[email protected] 16 DS：[email protected] 17 bioRxiv preprint doi: https://doi.org/10.1101/2021.09.02.458742; this version posted September 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 18 Abstract 19 A cavernous hemangioma, well-known as vascular malformation, is present at birth, grows 20 proportionately with the child, and does not undergo regression.
    [Show full text]
  • Application of Whole Genome Sequencing for Diagnosis of Intellectual Disability in a Multiethnic Cohort- Initial Findings and Reanalysis
    Application of Whole Genome Sequencing for diagnosis of Intellectual Disability in a multiethnic cohort- initial findings and reanalysis Madhura Bakshi A thesis in fulfilment of the requirements for the degree of Master of Science St. Vincent’s Clinical School Faculty of Medicine February 2020 Thesis/Dissertation Sheet Surname/Family Name : Bakshi Given Name/s : Madhura Abbreviation for degree as given in the University : MSc calendar Faculty : Faculty of Medicine School : St. Vincent’s Clinical School Application of Whole Genome Sequencing for diagnosis of Intellectual Thesis Title : Disability in a multiethnic cohort – initial findings and reanalysis Abstract 350 words maximum: (PLEASE TYPE) Whole genome sequencing (WGS) is a powerful tool for diagnosis of Mendelian disorders. This study is aimed at evaluating the utility of WGS for molecular diagnosis of a multiethnic Intellectual Disability(ID) cohort. Individuals were recruited through the Clinical Genetics department of a tertiary hospital in New South Wales, Australia, over three years. All patients had varying degrees of syndromic or non-syndromic ID; some had neurological syndromes. WGS was undertaken using singleton, duo or trio approach after assessment of clinical features, family history and screening genetic investigations. Next Generation Sequencing (NGS) technology was utilised for sequencing and analysing genomic data at Genome.One, a NATA accredited WGS laboratory in Australia. Analysis included sequence variation and copy number limited to exonic and flanking splice site regions of known Mendelian disease-causing genes. Families where no diagnosis was made on initial analysis, were reanalysed two years later. A total of 46 probands from 43 families underwent WGS. There were 8/43 (18%) consanguineous families.
    [Show full text]
  • Datasheet: VMA00222 Product Details
    Datasheet: VMA00222 Description: MOUSE ANTI TUBULIN BETA 2A CHAIN Specificity: TUBULIN BETA 2A CHAIN Format: Purified Product Type: PrecisionAb™ Monoclonal Isotype: IgG1 Quantity: 100 µl Product Details Applications This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit www.bio-rad-antibodies.com/protocols. Yes No Not Determined Suggested Dilution Western Blotting 1/1000 PrecisionAb antibodies have been extensively validated for the western blot application. The antibody has been validated at the suggested dilution. Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Further optimization may be required dependant on sample type. Target Species Human Species Cross Reacts with: Mouse, Rat Reactivity N.B. Antibody reactivity and working conditions may vary between species. Product Form Purified IgG - liquid Preparation Mouse monoclonal antibody prepared by affinity chromatography on Protein G Buffer Solution Phosphate buffered saline Preservative 0.09% Sodium Azide (NaN3) Stabilisers Immunogen Recombinant protein corresponding to amino acids 25-187 of human tubulin beta 2A chain expressed in E. coli External Database UniProt: Links Q13885 Related reagents Entrez Gene: 7280 TUBB2A Related reagents Page 1 of 2 Synonyms TUBB2 Specificity Mouse anti Human tubulin beta 2A chain antibody recognizes the tubulin beta 2A chain, also known as class IIa beta-tubulin, tubulin beta class IIa and tubulin beta polypeptide 2. Mouse anti Human tubulin beta 2A chain antibody detects a band of 52 kDa.
    [Show full text]
  • Early Onset Ataxia with Comorbid Dystonia: Clinical, Anatomical and Biological Pathway Analysis Expose Shared Pathophysiology
    diagnostics Article Early Onset Ataxia with Comorbid Dystonia: Clinical, Anatomical and Biological Pathway Analysis Expose Shared Pathophysiology 1, , 1, 1 1 Deborah A. Sival * y, Martinica Garofalo y , Rick Brandsma , Tom A. Bokkers , Marloes van den Berg 1, Tom J. de Koning 2,3, Marina A. J. Tijssen 2 and Dineke S. Verbeek 3 1 Department of Paediatric Neurology, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands; [email protected] (M.G.); [email protected] (R.B.); [email protected] (T.A.B.); [email protected] (M.v.d.B.) 2 Department of Neurology, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands; [email protected] (T.J.d.K.); [email protected] (M.A.J.T.) 3 Department of Genetics, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands; [email protected] * Correspondence: [email protected] These authors fulfill requirements for first authorship. y Received: 7 October 2020; Accepted: 16 November 2020; Published: 24 November 2020 Abstract: In degenerative adult onset ataxia (AOA), dystonic comorbidity is attributed to one disease continuum. However, in early adult onset ataxia (EOA), the prevalence and pathogenesis of dystonic comorbidity (EOAD+), are still unclear. In 80 EOA-patients, we determined the EOAD+-prevalence in association with MRI-abnormalities. Subsequently, we explored underlying biological pathways by genetic network and functional enrichment analysis.
    [Show full text]
  • Insertional Mutagenesis in Mice Deficient for P15ink4b, P16ink4a, , and P27kip1 Reveals Cancer Gene Interactions and Correlation
    Published OnlineFirst January 12, 2010; DOI: 10.1158/0008-5472.CAN-09-2736 Published Online First on January 12, 2010 as 10.1158/0008-5472.CAN-09-2736 Molecular and Cellular Pathobiology Cancer Research Insertional Mutagenesis in Mice Deficient for p15Ink4b, p16Ink4a, p21Cip1, and p27Kip1 Reveals Cancer Gene Interactions and Correlations with Tumor Phenotypes Jaap Kool1, Anthony G. Uren1, Carla P. Martins1, Daoud Sie2, Jeroen de Ridder3,4, Geoffrey Turner5, Miranda van Uitert3, Konstantin Matentzoglu1, Wendy Lagcher1, Paul Krimpenfort1, Jules Gadiot1, Colin Pritchard1, Jack Lenz5, Anders H. Lund1, Jos Jonkers3, Jane Rogers6, David J. Adams6, Lodewyk Wessels3,4, Anton Berns1, and Maarten van Lohuizen1 Abstract The cyclin dependent kinase (CDK) inhibitors p15, p16, p21, and p27 are frequently deleted, silenced, or downregulated in many malignancies. Inactivation of CDK inhibitors predisposes mice to tumor development, showing that these genes function as tumor suppressors. Here, we describe high-throughput murine leukemia virus insertional mutagenesis screens in mice that are deficient for one or two CDK inhibitors. We retrieved 9,117 retroviral insertions from 476 lymphomas to define hundreds of loci that are mutated more frequently than expected by chance. Many of these loci are skewed toward a specific genetic context of predisposing germline and somatic mutations. We also found associations between these loci with gender, age of tumor onset, and lymphocyte lineage (B or T cell). Comparison of retroviral insertion sites with single nucleotide polymorphisms associated with chronic lymphocytic leukemia revealed a significant overlap between the datasets. Together, our findings highlight the importance of genetic context within large-scale mutation detection studies, and they show a novel use for insertional mutagenesis data in prioritizing disease-associated genes that emerge from genome-wide association studies.
    [Show full text]
  • Datasheet: VMA00222K Product Details
    Datasheet: VMA00222K Description: TUBULIN BETA 2A CHAIN ANTIBODY WITH CONTROL LYSATE Specificity: TUBULIN BETA 2A CHAIN Format: Purified Product Type: PrecisionAb™ Monoclonal Isotype: IgG1 Quantity: 10 Westerns Product Details Applications This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit www.bio-rad-antibodies.com/protocols. Yes No Not Determined Suggested Dilution Western Blotting 1/1000 PrecisionAb antibodies have been extensively validated for the western blot application. The antibody has been validated at the suggested dilution. Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Further optimization may be required dependant on sample type. Target Species Human Species Cross Reacts with: Mouse, Rat Reactivity N.B. Antibody reactivity and working conditions may vary between species. Product Form Purified IgG - liquid Preparation 100μl Mouse monoclonal antibody prepared by affinity chromatography on Protein G Buffer Solution Phosphate buffered saline Preservative 0.09% Sodium Azide (NaN3) Stabilisers Immunogen Recombinant protein corresponding to amino acids 25-187 of human tubulin beta 2A chain expressed in E. coli External Database UniProt: Links Q13885 Related reagents Entrez Gene: 7280 TUBB2A Related reagents Page 1 of 3 Synonyms TUBB2 Specificity Mouse anti Human tubulin beta 2A chain antibody recognizes the tubulin beta 2A chain, also known as class IIa beta-tubulin, tubulin beta class IIa and tubulin beta polypeptide 2.
    [Show full text]